201 related articles for article (PubMed ID: 22090266)
1. Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.
Yin MT; Zhang CA; McMahon DJ; Ferris DC; Irani D; Colon I; Cremers S; Shane E
J Clin Endocrinol Metab; 2012 Feb; 97(2):554-62. PubMed ID: 22090266
[TBL] [Abstract][Full Text] [Related]
2. Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.
Yin MT; Shu A; Zhang CA; Boutroy S; McMahon DJ; Ferris DC; Colon I; Shane E
Calcif Tissue Int; 2013 Jun; 92(6):557-65. PubMed ID: 23460340
[TBL] [Abstract][Full Text] [Related]
3. Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.
Yin MT; McMahon DJ; Ferris DC; Zhang CA; Shu A; Staron R; Colon I; Laurence J; Dobkin JF; Hammer SM; Shane E
J Clin Endocrinol Metab; 2010 Feb; 95(2):620-9. PubMed ID: 19965927
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE; Kanter JR; Grinspoon S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
[TBL] [Abstract][Full Text] [Related]
5. Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study.
Garnero P; Borel O; Sornay-Rendu E; Duboeuf F; Jeffery R; Woo P; Delmas PD
Bone; 2002 Jul; 31(1):43-50. PubMed ID: 12110411
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
Sharma A; Cohen HW; Freeman R; Santoro N; Schoenbaum EE
Maturitas; 2011 Nov; 70(3):295-301. PubMed ID: 21944566
[TBL] [Abstract][Full Text] [Related]
7. Bone mass and mineral metabolism in HIV+ postmenopausal women.
Yin M; Dobkin J; Brudney K; Becker C; Zadel JL; Manandhar M; Addesso V; Shane E
Osteoporos Int; 2005 Nov; 16(11):1345-52. PubMed ID: 15754081
[TBL] [Abstract][Full Text] [Related]
8. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Human Immunodeficiency Virus and Menopause on Bone Mineral Density: A Longitudinal Study of Urban-Dwelling South African Women.
Madanhire T; Goedecke JH; Ward KA; Jaff N; Crowther NJ; Norris S; Ferrand RA; Rehman AM; Micklesfield LK; Gregson CL
J Bone Miner Res; 2023 May; 38(5):619-630. PubMed ID: 36726211
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in bone loss and relation to menopause among HIV-infected and uninfected women.
Sharma A; Flom PL; Rosen CJ; Schoenbaum EE
Bone; 2015 Aug; 77():24-30. PubMed ID: 25896953
[TBL] [Abstract][Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
12. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
[TBL] [Abstract][Full Text] [Related]
13. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
Han W; Bai X; Wang N; Han L; Sun X; Chen X
Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
[TBL] [Abstract][Full Text] [Related]
14. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
[TBL] [Abstract][Full Text] [Related]
16. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Bone HG; Bolognese MA; Yuen CK; Kendler DL; Wang H; Liu Y; San Martin J
J Clin Endocrinol Metab; 2008 Jun; 93(6):2149-57. PubMed ID: 18381571
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study.
Ellis C; Kruger HS; Viljoen M; Dave JA; Kruger MC
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34207469
[TBL] [Abstract][Full Text] [Related]
18. Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women.
Gourlay ML; Preisser JS; Hammett-Stabler CA; Renner JB; Rubin J
Osteoporos Int; 2011 Oct; 22(10):2699-708. PubMed ID: 21125395
[TBL] [Abstract][Full Text] [Related]
19. Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate.
Earnshaw SA; Cawte SA; Worley A; Hosking DJ
Osteoporos Int; 1998; 8(1):53-60. PubMed ID: 9692078
[TBL] [Abstract][Full Text] [Related]
20. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women.
Murphy E; Glüer CC; Reid DM; Felsenberg D; Roux C; Eastell R; Williams GR
J Clin Endocrinol Metab; 2010 Jul; 95(7):3173-81. PubMed ID: 20410228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
